NCT05765461
Completed
Not Applicable
Effect of Lipikar Baume AP+M on Quality of Life and Pain Related to Atopic Dermatitis and Other Skin Diseases With Dryness or Severe Xerosis on Adults
Cosmetique Active International1 site in 1 country4,631 target enrollmentStarted: December 31, 2019Last updated:
Overview
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 4,631
- Locations
- 1
- Primary Endpoint
- change in the intensity of skin disease
Overview
Brief Summary
This study aims at evaluating the effect of a topical product on the improvement of quality of life and pain of patients suffering from atopic dermatitis or other skin diseases with dryness or severe xerosis. Patients aged 16 years and over are asked to apply the product once or twice a day for 2 months. They may be prescribed a corticosteroid upon decision of the dermatologist.
Detailed Description
The general approach of the statistical methodology is the following:
- The qualitative variables are described with number and percent of each level.
- The quantitative variables are described with mean and standard deviation.
- All statistical hypotheses are performed at the 5% significance level using 2-sided tests.
- Given the large sample size, no normality assessment will be done.
- Mean reduction rate for quantitative variables is calculated as (mean v0 - mean v1)/mean v0)*100.
- Due to the high number of zeros at inclusion in the self-assessment quantitative criteria, analyses will concern only patient with an intensity above 0 at inclusion or at final visit.
- Response rate for qualitative variables is calculated as the percent of patients with at least on level decrease between the two visits.
- Response rate for satisfaction is the percent of patients declaring being Satisfied or Very satisfied.
- Response rate for tolerance is the percent of patients declaring the tolerance High or Excellent.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •atopic dermatitis or other skin disease with dryness or severe xerosis
Exclusion Criteria
- •patients not suffering from atopic dermatitis or other skin disease with dryness or severe xerosis
Outcomes
Primary Outcomes
change in the intensity of skin disease
Time Frame: from baseline to Day56
The dermatologist evaluates the intensity of the skin condition on a 5-point scale (from absent to very severe)
Secondary Outcomes
- change in the intensity of skin dryness(from baseline to Day56)
- evolution of the inflammatory lesions surface(from baseline to Day56)
- change in the intensity of pruritus(from baseline to Day56)
- change in the quality of sleep(from baseline to Day56)
- change in the daily discomfort(from baseline to Day56)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant ChemotherapyStomach NeoplasmsNCT04360577Guangzhou University of Traditional Chinese Medicine240
Completed
Not Applicable
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"Breast CancerNCT02134977Takeda2,816
Completed
Not Applicable
Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer PatientsQuality of LifeColorectal NeoplasmsNCT02321813Tumor Center Regensburg220
Not yet recruiting
Phase 4
Study to compare the efficacy and impact on quality of life of two types of repetitive transcranial magnetic stimulation in chronic migraine patientsHealth Condition 1: G437- Chronic migraine without auraCTRI/2024/03/064293Institute of Medical Sciences Banaras Hindu University
Recruiting
Not Applicable
Zypan Functional DyspepsiaDyspepsiaNCT06320379National University of Natural Medicine64